Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT03250130 Recruiting - Breast Cancer Clinical Trials

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)

HYPNOVAL
Start date: June 2015
Phase: N/A
Study type: Interventional

The main objective is to assess the feasibility of an intervention based on medical Ericksonian hypnosis as a complementary therapy in patients treated with surgery after a diagnosis of breast cancer, followed by an indication of adjuvant chemotherapy and radiotherapy

NCT ID: NCT03249389 Completed - Breast Cancer Clinical Trials

Assessing the Changes in Markers of Calcium Vitamin Metabolism of for Breast Cancer Adjuvant (CALCIOBS)

CALCIOBS
Start date: October 2015
Phase: N/A
Study type: Interventional

This study is to Assess hypercalciuria between J1 of the cure and 1 J1 6 of the cure of adjuvant chemotherapy in patients receiving conventional adjuvant chemotherapy of breast cancer.

NCT ID: NCT03248492 Not yet recruiting - Breast Cancer Clinical Trials

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Start date: August 2017
Phase: Phase 2
Study type: Interventional

Some HER-2 breast cancer patients do not respond or build resistance to current treatment. DS-8201a is a new experimental product that is a combination of an antibody and a drug. It has not yet been approved for use. DS-8201a may slow down tumor growth. This might improve outcomes for these patients.

NCT ID: NCT03248427 Recruiting - Breast Cancer Clinical Trials

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.

CORALLEEN
Start date: July 13, 2017
Phase: Phase 2
Study type: Interventional

CORALLEEN is a two-arm, randomized, multicentric study in postmenopausal women with primary HR+/HER2 negative Luminal B breast cancer that will explore if the combination of ribociclib with letrozole offers clinical benefit at least comparable to that of standard chemotherapy.

NCT ID: NCT03245788 Recruiting - Breast Cancer Clinical Trials

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study

Start date: February 15, 2017
Phase: N/A
Study type: Interventional

The Stanford Cancer Center is undertaking a Transformation Initiative in order to improve the quality of care, make it more patient-centered and coordinated across the continuum of care. The newest innovation is to introduce lay navigators to specified high-need patients. The larger goal of the project is to assess whether lay navigators can address non-clinical patient needs in a timely fashion and appropriately connect them with their clinical team when warranted. It is expected that proactive interaction with patients will decrease patient anxiety/stress related to their cancer and facilitate higher patient engagement and improved management of physical, social,and emotional health. For the pilot project, the smaller goal is to understand: how lay navigator time is used; the types and frequency of issues brought up by patients; resources that patients are given or referred to; type and frequency of mode of contact with patients; and patients' acceptance of navigators based on refusal. An electronic intake form will be used to collect this information so that data can be analyzed regularly and informed change can be made to the navigator program as needed

NCT ID: NCT03243877 Recruiting - Breast Cancer Clinical Trials

Performance of MammoAlertâ„¢, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older

Start date: June 17, 2017
Phase: N/A
Study type: Observational

POC Medical Systems has developed a Point of Care system for the screening of breast cancer in the general population. Via a proprietary algorithm, the MammoAlertâ„¢ is expected to determine breast cancer's risk level for a subject by identifying the presence in plasma of known biomarkers. The present study aims to determine the Sensitivity and Specificity of the test in plasma samples of subjects of whom the status vis-à-vis breast cancer is known.

NCT ID: NCT03243786 Recruiting - Breast Cancer Clinical Trials

Stay on Track: A Study of Exercise Effects During Radiation

Start date: April 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the impact of a lifestyle intervention. The study will examine the Stay on Track program, dietary and activity patterns, body composition, biomarkers and quality of life in breast cancer patients undergoing radiation therapy.

NCT ID: NCT03239756 Recruiting - Breast Cancer Clinical Trials

Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases

Start date: July 20, 2017
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, dose-escalating study to evaluate the safety, pharmacokinetics, immunogenicity, and preliminary efficacy of single and multiple subcutaneous injection TK006 in patients with breast cancer-related bone metastases.

NCT ID: NCT03238976 Not yet recruiting - Breast Cancer Clinical Trials

Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy

Start date: October 2017
Phase: N/A
Study type: Interventional

Patients will be randomly assigned to one of two groups: the group exposed to NS, or the standard care group exposed to supportive dialogue. Patients assigned to the former group will be exposed to continuous NS throughout the CNB procedure.

NCT ID: NCT03238053 Not yet recruiting - Breast Cancer Clinical Trials

Laser Treatment of Genito-urinary Syndrome in Women

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Women with genitourinary syndrome of menopause, with breast or endometrial cancer are randomized to either laser treatment og sham treatment for 3 months. The randomization is stratified for estrogen treatment. The effect is evaluated by questionnaire, histology and microbiology swaps